# Pharmacokinetics and Safety Study of Tapentadol for Postsurgical Pain in Children and Adolescents

> **NCT01134536** · PHASE2 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 45 (actual)

## Conditions studied

- Pain, Postoperative
- Postoperative Pain

## Interventions

- **DRUG:** Tapentadol (OS) Oral Solution

## Key facts

- **NCT ID:** NCT01134536
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2014-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01134536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01134536, "Pharmacokinetics and Safety Study of Tapentadol for Postsurgical Pain in Children and Adolescents". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01134536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*